Home › Research › Brain tissue and pathology
The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes
Dong‐Hwi Kim, Dong-Hwi Kim, Jae‐Hyeong Kim, Min‐Tae Jeon, Kyu‐Sung Kim, Do-Geun Kim, Do-Geun Kim, In-Soo Choi. Viruses, 2025-05-19
Topic: Brain proteins, microglia and lab models
Plain-language summary
The coronavirus disease 2019 (COVID-19) pandemic has been linked to long-term neurological effects with multifaceted complications of neurodegenerative diseases. Several studies have found that pathological changes in transactive response DNA-binding protein of 43 kDa (TDP-43) are involved in these cases. This review explores the causal interactions between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and TDP-43 from multiple perspectives. Some viral proteins of SARS-CoV-2 have been shown to induce pathological changes in TDP-43 through its cleavage, aggregation, and mislocalization. SARS-CoV-2 infection can cause liquid-liquid phase separation and stress granule formation, which accelerate the condensation of TDP-43, resulting in host RNA metabolism disruption. TDP-43 has been proposed to interact with SARS-CoV-2 RNA, though its role in viral replication remains to be fully elucidated. This interaction potentially facilitates viral replication, while viral-induced oxidative stress and protease activity accelerate TDP-43 pathology. Evidence from both clinical and experimental studies indicates that SARS-CoV-2 infection may contribute to long-term neurological sequelae, including amyotrophic lateral sclerosis-like and frontotemporal dementia-like features, as well as increased phosphorylated TDP-43 deposition in the central nervous system. Biomarker studies further support the link between TDP-43 dysregulation and neurological complications of long-term effects of COVID-19 (long COVID). In this review, we presented a novel integrative framework of TDP-43 pathology, bridging a gap between SARS-CoV-2 infection and mechanisms of neurodegeneration. These findings underscore the need for further research to clarify the TDP-43-related neurodegeneration underlying SARS-CoV-2 infection and to develop therapeutic strategies aimed at mitigating long-term neurological effects in patients with long COVID.
What this study adds
Evidence grade: Low
This review describes evidence that SARS-CoV-2 infection may contribute to long-term neurological problems resembling ALS and frontotemporal dementia, along with increased phosphorylated TDP-43 in the central nervous system. It concludes that more research is needed to clarify this TDP-43-related neurodegeneration and to develop ways to reduce it.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kim, D., Kim, D.-H., Kim, J., Jeon, M., Kim, K., Kim, D.-G., et al. (2025). The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes. Viruses. https://doi.org/10.3390/v17050724
Vancouver
Kim D, Kim D.-H, Kim J, Jeon M, Kim K, Kim D.-G, et al. The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes. Viruses. 2025. doi:10.3390/v17050724. PMID: 40431734.
BibTeX
@article{kim2025-40431734,
author = {Kim, Dong‐Hwi and Kim, Dong-Hwi and Kim, Jae‐Hyeong and Jeon, Min‐Tae and Kim, Kyu‐Sung and Kim, Do-Geun and Choi, In-Soo},
title = {{The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes}},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050724},
pmid = {40431734},
url = {https://doi.org/10.3390/v17050724}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Evidence from both clinical and experimental studies indicates that SARS-CoV-2 infection may contribute to long-term neurological sequelae, including amyotrophic lateral sclerosis-like and frontotemporal dementia-like features, as well as increased phosphorylated TDP-43 deposition in the central nervous system.
- These findings underscore the need for further research to clarify the TDP-43-related neurodegeneration underlying SARS-CoV-2 infection and to develop therapeutic strategies aimed at mitigating long-term neurological effects in patients with long COVID.
Why it matters
This review describes evidence that SARS-CoV-2 infection may contribute to long-term neurological problems resembling ALS and frontotemporal dementia, along with increased phosphorylated TDP-43 in the central nervous system. It concludes that more research is needed to clarify this TDP-43-related neurodegeneration and to develop ways to reduce it.
Study details
- Evidence strengthLow
How this study scored 39/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Viruses) |
| Journal's citation record | 2 / 4 | Viruses: journal h-index 187 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 7 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author In-Soo Choi: h-index 8 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Korea Institute of Science and Technology: institution h-index 445 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40431734) |
| Free to read | 2 / 2 | Free to read |
| Total | 39 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 18.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Brain tissue and pathology from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.